0.386
price up icon9.32%   0.0329
 
loading

Passage Bio Inc (PASG) 最新ニュース

pulisher
Mar 31, 2025

Passage Bio stock plunges to 52-week low of $0.35 By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Passage Bio stock plunges to 52-week low of $0.35 - Investing.com

Mar 31, 2025
pulisher
Mar 28, 2025

Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace

Mar 28, 2025
pulisher
Mar 27, 2025

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

Krabbe Disease Treatment Market is to grow at a 7.22 % CAGR, with the United States leading the market through 2032 - StreetInsider.com

Mar 27, 2025
pulisher
Mar 25, 2025

Strategic Partnership To Advance Gene Therapies For Rare Diseases: Key Trend in The GM1 Gangliosidosis Glob... - WhaTech

Mar 25, 2025
pulisher
Mar 23, 2025

Annovis Bio Reports Progress in Clinical Trials and Improved Financial Position - MyChesCo

Mar 23, 2025
pulisher
Mar 21, 2025

Fierce Biotech Layoff Tracker 2025: Elevation eliminates 70% of staff; Vaxart trims team - Fierce Biotech

Mar 21, 2025
pulisher
Mar 19, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Mar 19, 2025
pulisher
Mar 16, 2025

Third Arc Bio Enters Clinical Stage with First Patient Dosed in ARC101 Study - MyChesCo

Mar 16, 2025
pulisher
Mar 13, 2025

Passage Bio stock plunges to 52-week low of $0.38 amid market challenges - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Passage Bio stock plunges to 52-week low of $0.38 amid market challenges By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 13, 2025

Annovis Bio to Showcase Advancements at Alzheimer’s & Parkinson’s Drug Development Summit - MyChesCo

Mar 13, 2025
pulisher
Mar 09, 2025

Passage Bio Reports 2024 Financial Results and Advances in PBFT02 Program - MSN

Mar 09, 2025
pulisher
Mar 08, 2025

Wedbush Comments on Passage Bio’s Q1 Earnings (NASDAQ:PASG) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Passage Bio (PASG) Upgraded to Buy: Here's What You Should Know - Nasdaq

Mar 07, 2025
pulisher
Mar 07, 2025

FY2029 Earnings Forecast for Passage Bio Issued By Wedbush - Defense World

Mar 07, 2025
pulisher
Mar 05, 2025

Chardan Cuts Price Target on Passage Bio to $6 From $7, Keeps Buy Rating -March 05, 2025 at 07:36 am EST - Marketscreener.com

Mar 05, 2025
pulisher
Mar 05, 2025

Passage Bio (NASDAQ:PASG) Price Target Lowered to $6.00 at Chardan Capital - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Passage Bio Advances Gene Therapy for Neurodegenerative Diseases - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Strategic Restructuring and Promising Data Catalysts Drive Buy Rating for Passage Bio - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Chardan cuts Passage Bio stock price target to $6, maintains buy - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Chardan cuts Passage Bio stock price target to $6, maintains buy By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Passage Bio stock plunges to 52-week low of $0.45 - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Passage Bio stock plunges to 52-week low of $0.45 By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Passage Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

2025 Market Prospects of Adeno-Associated Virus Vectors in Gene Therapy Pipeline: 200 Pipeline Drugs and the Strategic Workings of 180+ Companies - GlobeNewswire Inc.

Mar 04, 2025
pulisher
Mar 04, 2025

PASSAGE BIO, INC. Full Year Loss Decreases - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

Passage Bio Reports 2024 Financial Results and Program Advances - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

Passage BIO, Inc. SEC 10-K Report - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

Passage Bio reports FY24 EPS ($1.07) vs ($1.86) last year - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Passage Bio Reports Fourth Quarter and Full Year 2024 Results -March 04, 2025 at 07:07 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Passage Bio Reports Promising Interim Data for PBFT02 in FTD-GRN Patients and Provides Business Updates - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent - The Bakersfield Californian

Mar 04, 2025
pulisher
Mar 04, 2025

Can Passage Bio's FTD-GRN Treatment Breakthrough Translate to Market Success? - StockTitan

Mar 04, 2025
pulisher
Mar 02, 2025

Passage Bio to Present at Two Major Investor Conferences - MSN

Mar 02, 2025
pulisher
Mar 01, 2025

Passage Bio (PASG) to Release Quarterly Earnings on Monday - Defense World

Mar 01, 2025
pulisher
Feb 26, 2025

Passage Bio to Participate in Upcoming Investor Conferences - GlobeNewswire

Feb 26, 2025
pulisher
Feb 26, 2025

Genetic Medicine Pioneer Passage Bio Sets March Investor Conference Schedule - StockTitan

Feb 26, 2025
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
大文字化:     |  ボリューム (24 時間):